Form 4: Camden National Corp Executive Stock Grant

EVP David Ackley acquired 1,087 shares of Camden National Corp common stock via a restricted stock award grant.

Summary

• David Ackley, EVP of Camden National Corp, was granted 1,087 shares of common stock.
• The transaction occurred on April 28, 2026, at a price of $50.67 per share.
• Following this transaction, the reporting person holds a total of 13,634.958 shares.
• The grant is part of the issuer's 2022 Equity and Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected and routine.

Positives

• Alignment of executive interests with shareholders through equity-based compensation.
• The grant includes a three-year pro-rata vesting schedule, encouraging long-term retention.

Negatives

• None identified; this is a standard executive compensation disclosure.

Risks

• Vesting is subject to continued employment, creating potential forfeiture risk if the executive leaves the company.

Future Outlook

The restricted stock awards are scheduled to vest pro-rata over the next three years, contingent upon continued employment.

Industry Context

StockSavvy.ai notes that equity grants for bank executives are standard practice to ensure long-term alignment with institutional performance and shareholder value.

Comparison to Industry Standards

• The use of a three-year pro-rata vesting schedule is consistent with standard corporate governance practices for regional banking institutions.
• The disclosure follows standard SEC Section 16(a) reporting requirements for executive officers.

Stakeholder Impact

• Shareholders benefit from the alignment of executive incentives with long-term company performance.

Next Steps

• Vesting of the 1,087 restricted shares over the next three years.

Key Dates

Keywords

Camden National Corp, CAC, Form 4, Insider Trading, Executive Compensation, Restricted Stock